1. Home
  2. DERM

as 10-07-2025 3:30pm EST

$
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.

Founded: 2014 Country:
United States
United States
Employees: N/A City: SCOTTSDALE
Market Cap: 190.7M IPO Year: 2021
Target Price: $12.67 AVG Volume (30 days): 92.2K
Analyst Decision: Strong Buy Number of Analysts: 3
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.40 EPS Growth: N/A
52 Week Low/High: $3.54 - $8.90 Next Earning Date: 11-11-2025
Revenue: $56,397,000 Revenue Growth: -27.40%
Revenue Growth (this year): 26.25% Revenue Growth (next year): 52.96%

Share on Social Networks: